✦ LIBER ✦

Bevacizumab as First-Line Therapy for Patients With Brain Metastases From Renal Carcinoma: A Case Series

✍ Scribed by Zustovich, Fable; Ferro, Alessandra; Farina, Patrizia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of bevacizumab

✍ Hsu, C-H; Yang, T-S; Hsu, C; Toh, H C; Epstein, R J; Hsiao, L-T; Chen, P-J; Lin, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

Salvage Therapy with Bevacizumab–Sunitin

✍ Jacques Medioni; Eugeniu Banu; Dominique Helley; Florian Scotte; Laure Fournier; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Prognostic Factors of Survival for Patie

✍ Vickers, Michael M.; Al-Harbi, Hulayel; Choueiri, Toni K.; Kollmannsberger, Chri 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 314 KB

Phase II study of FOLFOX, bevacizumab an

✍ Meyerhardt, J.; Stuart, K.; Fuchs, C.; Zhu, A.; Earle, C.; Bhargava, P.; Blaszko 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 84 KB

Prognostic Significance of Cytoreductive

✍ Bamias, Aristotle; Tzannis, Kimon; Papatsoris, Athanasios; Oudard, Stéphane; Beu 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 803 KB

Axitinib versus sorafenib as first-line

✍ Hutson, Thomas E; Lesovoy, Vladimir; Al-Shukri, Salman; Stus, Viktor P; Lipatov, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 317 KB